MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that further to the announcement of the Placing and Open Offer on 26 November 2018, it has conditionally raised total gross proceeds of £78,778 via the Open Offer.

The Open Offer closed for acceptances at 11.00 a.m. on 11 December 2018. The Company received valid acceptances from Qualifying Shareholders in respect of 926,801 Open Offer Shares, including applications for 63,354 Open Offer Shares under the Excess Application Facility. This represents 3.8 per cent. of the maximum Open Offer Shares available under the Open Offer. Admission of the Open Offer shares is subject to passing the relevant resolutions at the General Meeting.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 26 November 2018.

Enquiries:

MedaPhor Group plc

www.medaphor.com

Tel: +44 (0)29 2075 6534

Stuart Gall, CEO
Wilson Jennings, CFO
Cenkos Securities - Nominated Advisor and broker
 Tel: +44 (0)20 7397 8900

Mark Connelly / Cameron MacRitchie (Corporate Finance)

Michael Johnson / Julian Morse (Sales)

Walbrook PR

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com
Anna Dunphy / Paul McManus
Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893

Attachments

  • Original document
  • Permalink

Disclaimer

IP Group plc published this content on 12 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 12 December 2018 11:04:07 UTC